CTOs on the Move

ProCare Rx

www.procarerx.com

 
ProCare Rx is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.procarerx.com
  • 3090 Premiere Pkwy Ste 100
    Duluth, GA USA 30097
  • Phone: 678.248.3105

Executives

Name Title Contact Details

Similar Companies

MedVet

MedVet Medical & Cancer Centers for Pets has 5 different locations: MedVet Columbus 300 E. Wilson Bridge Rd. Wothington, OH 43085 614-846-5800 800-891-9010 MedVet Cincinnati 3964 RedBank Rd. Fairfax, OH 45227 513-561-0069 877-841-5818 ...

Alcohol Research Group

Alcohol Research Group is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Juvly

Juvly Aesthetics is the fastest growing aesthetics practice in the United States, expanding since 2014, from a single location in Columbus, Ohio to eleven locations across the United States! Our team has gone from servicing just 10 clients to over 53,000 in five short years! The core of this growth stems from our unique values, which include; providing fantastic, natural-beauty enhancing results, transparent prices, and excellent customer service. Whether you are a client looking for first class services, or an eager employment-seeker, Juvly is the place for you!

PepperPointe Partnerships

PepperPointe Partnerships is a dental service organization (DSO) that provides support with non-clinical tasks to dental practices, allowing practitioners to focus on providing excellent patient care. PepperPointe seeks to redefine what it means to be ...

NeuroPace

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world`s first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company`s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.